Investor FAQs

When was Myriad Genetics founded?
Myriad Genetics was founded in May 1991.
Where are your corporate headquarters?
Our corporate headquarters and all our facilities are located at 322 North 2200 West, Salt Lake City, Utah 84116
When did Myriad Genetics become a public company?
We completed our initial public offering in October 1995.
What is Myriad Genetics’ CUSIP number?
Our CUSIP number is 62855J104.
What is your stock symbol?
Our common stock is listed on the Nasdaq Global Select Market under the symbol “MYGN”.
How can I buy Myriad Genetics stock?
You may purchase our stock through a registered stock broker, bank or through a financial institution that provides brokerage services. Myriad Genetics does not offer a direct purchase plan for investors.
What is the calendar fiscal year for Myriad Genetics?
Our calendar fiscal year ends on December 31.
When do Myriad Genetics’ calendar fiscal quarters end?
• First quarter – March 31
• Second quarter – June 30
• Third quarter – September 30
• Fourth quarter – December 31
Who is Myriad Genetics’ transfer agent?
Our transfer agent is American Stock Transfer & Trust Company. They are responsible for maintaining all records of registered shareholders (including change of address and name), cancelling or issuing stock certificates and resolving problems related to lost, destroyed or stolen certificates. If your shares are held in Street name, you will have to contact your broker for these services. You may contact our transfer agent at:

American Stock Transfer & Trust Company
59 Maiden Lane
New York, New York 10038
(800) 937-5449
(718) 921-8124
www.amstock.com
Who should I contact for information about my shareholder account?
If you have questions about your shareholder account you should contact our transfer agent, American Stock Transfer & Trust Company at (800) 937-5499. How do I contact Myriad Genetics’ investor relations department? Please contact Matt Scalo, Investor Relations, at: (801) 584-3532 or matt.scalo@myriad.com
How do I contact Myriad Genetics’ investor relations department?
Please contact Matt Scalo, Investor Relations, at: (801) 584-3532 or matt.scalo@myriad.com